Human IL-1ra ( #130-096-142 )

Human IL-1ra

Overview

IL-1ra stands for interleukin 1 receptor antagonist. Human IL-1ra is a recombinant protein optimized for use in cell culture, differentiation studies, and functional assays.

Human IL-1ra can be used for a variety of applications, including:

Regulation of IL-1 expression.
Competitive inhibition of IL-1 receptor binding (in vitro and in vivo).
Inhibition of IL-1 release.
Studies of anti-inflammatory effects.
Protection from endotoxin effects.

Details

Background information
IL-1ra is a naturally occurring anti-inflammatory protein secreted by macrophages, monocytes, neutrophils, fibroblasts, and epithelial cells. IL-1ra, a member of the IL-1 family, binds to IL-1 receptors in competition with IL-1 without inducing any cellular responses. It inhibits the activity of IL-1α and IL-1β by competitively blocking their type I and type II receptors. Furthermore, IL-1ra inhibits the secretion of IL-2 and the expression of IL-2 receptors. It has been shown that IL-1ra is capable of blocking the inflammatory responses induced by IL-1 both in vitro and in vivo. The non-glycosylated recombinant human IL-1ra expressed in E. coli blocks binding of IL-1 as well as the glycosylated natural form. The protein shows 26% amino acid homology to IL-1β and 19% homology to IL-1α. It has been shown that excess amounts of IL-1ra are necessary in in vitro systems to show significant inhibition of IL-1 induced responses.

Quality description
Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/µg (<1 EU/µg), and purities are >95%. The biological activity is tested in appropriate bioassays.